Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01790373 · ClinicalTrials.gov registry record · NA

Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence

A NA study of HIV, sponsored by Washington University School of Medicine.

Active
Registry status
NA
Development phase
702
Enrollment target
2
Study locations

NCT01790373 is a NA study of HIV that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 702 participants, above the 438-participant average among 303 other HIV trials with a reported enrollment target (60% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01790373, a NA study of HIV, is active but no longer recruiting, sponsored by Washington University School of Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
702 participants
Enrollment target
2
Study locations

Study Summary

The goal of Suubi+Adherence is to examine the impact and cost associated with an innovative intervention to increase adherence to HIV treatment for HIV-infected adolescents. Multiple intervention studies by our team in Rakai and Masaka Districts of southern Uganda with AIDS-orphaned adolescents have revealed that if given an opportunity to participate in economic empowerment interventions, youth and their caregivers take full advantage of these interventions to save and invest in their future, show improvements in family financial outcomes, future aspirations, health functioning, sexual-risk taking behaviors, and mental health. The Suubi+Adherence study capitalizes on this prior work, positing that economic empowerment may be a missing, yet critical ingredient to HIV treatment adherence interventions for adolescents and young people. Suubi+Adherence incorporates an economic empowerment design, with a savings-led income generating component, to promote economic stability, and apply it to adherence to HIV treatment regimens for HIV-positive adolescents in a region of southern Uganda with the highest HIV incidence and prevalence in the country.

Conditions Studied

HIV

Interventions

  • BEHAVIORAL Suubi+Adherence
  • BEHAVIORAL Bolstered Standard of Care

Study Locations (2)

Missouri

  • Washington University in St. Louis - St Louis

Other

  • International Center for Child Health and Asset Development - Masaka

Trial Details

FieldValue
Enrollment Target 702 participants
Start Date 2013-09-07
Est. Completion 2026-07-31
Phase NA

Sponsor

Washington University School of Medicine

1,502 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01790373

The ClinicalTrials.gov registry entry for NCT01790373 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 702 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 438-participant average among 303 other HIV trials with a reported enrollment target (60% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Suubi+Adherence is the first listed.

NCT01790373 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Missouri, Other.

Frequently Asked Questions

What is clinical trial NCT01790373 about?

NCT01790373 is a clinical study titled "Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence". The goal of Suubi+Adherence is to examine the impact and cost associated with an innovative intervention to increase adherence to HIV treatment for HIV-infected adolescents. Multiple intervention studies by our team in Rakai and Masaka Districts of southern Uganda with AIDS-orphaned adolescents have...

What is the current status of trial NCT01790373?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 702 participants. The study started on 2013-09-07. Estimated completion is 2026-07-31.

What conditions does trial NCT01790373 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT01790373?

The interventions under investigation include: Suubi+Adherence (BEHAVIORAL), Bolstered Standard of Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01790373?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01790373 being conducted?

This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.